References
- Alhadlaq M.A., Aljurayyad O.I., Almansour A., Al-Akeel S.I., Alzahrani K.O., Alsalman S.A., Yahya R., Al-Hindi R.R., Hakami M.A., Alshahrani S.D., Alhumeed N.A., Al Moneea A.M., Al-Seghayer M.S., AlHarbi A.L., Al-Reshoodi F.M., Alajel S.: Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982–2024) and food safety criteria. Gut Pathog 2024, 16, 57, doi: 10.1186/s13099-024-00641-9.
- Belousov M.V., Kosolapova A.O., Fayoud H., Sulatsky M.I., Sulatskaya A.I., Romanenko M.N., Bobylev A.G., Antonets K.S., Nizhnikov A.A.: OmpC and ompF outer membrane proteins of Escherichia coli and Salmonella enterica form bona fide amyloids.Int J Mol Sci 2023, 24, 15522, doi: 10.3390/ijms242115522.
- Butt S., Saleh M., Gagnon J.: Impact of the Escherichia coli heat-stable enterotoxin b (STb) on gut health and function. Toxins 2020, 12, 760, doi: 10.3390/toxins12120760.
- Cao Y.X., Ji P., Wu F.L., Dong J.Q., Li C.C., Ma T., Yang H.C., Wei Y.M., Hua Y.L.: Lonicerae Japonicae Caulis: a review of its research progress of active metabolites and pharmacological effects. Front Pharmacol 2023, 14, 1277283, doi: 10.3389/fphar.2023.1277283.
- Clinical and Laboratory Standards Institute: M100-Ed33 Performance Standards for Antimicrobial Susceptibility Testing. CLSI, Wayne, PA, USA, 2023.
- Farha M.A., Tu M.M., Brown E.D.: Important challenges to finding new leads for new antibiotics. Curr Opin Microbiol 2025, 83, 102562, doi: 10.1016/j.mib.2024.102562.
- Guan X., Jin L., Zhou H., Chen J., Wan H., Bao Y., Yang J., Yu D., Wan H.: Polydatin prevent lung epithelial cell from carbapenem-resistant Klebsiella pneumoniae injury by inhibiting biofilm formation and oxidative stress. Sci Rep 2023, 13, 17736, doi: 10.1038/s41598-023-44836-7.
- Li J., Feng S., Liu X., Jia X., Qiao F., Guo J., Deng S.: Effects of traditional Chinese medicine and its active ingredients on drug-resistant bacteria. Front Pharmacol 2022, 13, 837907, doi: 10.3389/fphar.2022.837907.
- Li X., Xia Y., Li G., Zhan Z., Yao R., Li M.: Traditional uses, phytochemistry, pharmacology, and toxicology of Akebiae Caulis and its synonyms: a review. J Ethnopharmacol 2021, 277, 114245, doi: 10.1016/j.jep.2021.114245.
- Liu B.G., Xie M., Dong Y., Wu H., He D.D., Hu G.Z., Xu E.P.: Antimicrobial mechanisms of traditional Chinese medicine and reversal of drug resistance: a narrative review. Eur Rev Med Pharmacol Sci 2022, 26, 5553–5561, doi: 10.26355/eurrev_202208_29426.
- Liu X., Zhang Y., Li Z., Zhang P., Sun Y.J., Wu Y.J.: Paeoniflorin derivative in Paeoniae Radix aqueous extract suppresses alpha-toxin of Staphylococcus aureus. Front Microbiol 2021, 12, 649390, doi: 10.3389/fmicb.2021.649390.
- Millar B.C., Rao J.R., Moore J.E.: Fighting antimicrobial resistance (AMR): Chinese herbal medicine as a source of novel antimicrobials - an update. Lett Appl Microbiol 2021, 73, 400–407, doi: 10.1111/lam.13534.
- Pan J., Liu Z., Liang Z., Wu Y., Song J., Sun Y., Xu S., Huang K., Si H.: Study on the anti-bacterial effects of aqueous extract of Radix Paeoniae Rubra combined with antibiotics against drug-resistant E. coli. China Anim Husb Vet Med 2015, 42, 3080–3086.
- Parmanik A., Das S., Kar B., Bose A., Dwivedi G.R., Pandey M.M.: Current treatment strategies against multidrug-resistant bacteria: a review. Curr Microbiol 2022, 79, 388, doi: 10.1007/s00284-022-03061-7.
- Ren Y.Y., Zhang X.R., Li T.N., Zeng Y.J., Wang J., Huang Q.W.: Galla Chinensis, a traditional Chinese Medicine: Comprehensive review of botany, traditional uses, chemical composition, pharmacology and toxicology. J Ethnopharmacol 2021, 278, 114247, doi: 10.1016/j.jep.2021.114247.
- Rocha L.B., Ozaki C.Y., Horton D.S.P.Q., Menezes C.A., Silva A., Fernandes I., Magnoli F.C., Vaz T.M.I., Guth B.E.C., Piazza R.M.F.: Different assay conditions for detecting the production and release of heat-labile and heat-stable toxins in enterotoxigenic Escherichia coli isolates. Toxins 2013, 5, 2384–2402, doi: 10.3390/toxins5122384.
- Ruan X., Deng X., Tan M., Yu C., Zhang M., Sun Y., Jiang N.: In vitro antibiofilm activity of resveratrol against avian pathogenic Escherichia coli. BMC Vet Res 2021, 17, 249, doi: 10.1186/s12917-021-02961-3.
- Su P.W., Yang C.H., Yang J.F., Su P.Y., Chuang L.Y.: Antibacterial activities and antibacterial mechanism of Polygonum cuspidatum extracts against nosocomial drug-resistant pathogens. Molecules 2015, 20, 11119–11130, doi: 10.3390/molecules200611119.
- Sun Y., Liu T., Zhao X.: Progress in the study of chemical structure and pharmacological effects of total paeony glycosides isolated from Radix paeoniae rubra. Curr Issues Mol Biol 2024, 46, 10065–10086, doi: 10.3390/cimb46090601.
- Tängdén T., Carrara E., Hellou M.M., Yahav D., Paul M.: Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward. Clin Microbiol Infect 2025, 31, 354–359, doi: 10.1016/j.cmi.2024.09.025.
- Tyers M., Wright G.D.: Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol 2019, 17, 141–155, doi: 10.1038/s41579-018-0141-x.
- van Duin D., Paterson D.L.: Multidrug-resistant bacteria in the community: an update. Infect Dis Clin North Am 2020, 34, 709–722, doi: 10.1016/j.idc.2020.08.002.
- Wang J., Wang L., Lou G.H., Zeng H.R., Hu J., Huang Q.W., Peng W., Yang X.B.: Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol 2019, 57, 193–225, doi: 10.1080/13880209.2019.1577466.
- Wang S.Y., Sun Z.L., Liu T., Gibbons S., Zhang W.J., Qing M.: Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA. Phytother Res 2014, 28, 1071–1076, doi: 10.1002/ptr.5098.
- Wang Y.M., Kong L.C., Liu J., Ma H.X.: Synergistic effect of eugenol with colistin against clinical isolated colistin-resistant Escherichia coli strains. Antimicrob Resist Infect Control 2018, 7, 17, doi: 10.1186/s13756-018-0303-7.
- Wang Z.J., Zhu Y.Y., Bai L.Y., Tang D.M., Zhou Z.S., Wei M.Z., He J.B., Duan Y., Luo X.D.: A new therapeutic strategy for infectious diseases against intracellular multidrug-resistant bacteria. J Control Release 2024, 375, 467–477, doi: 10.1016/j.jconrel.2024.09.028.
- Xue Z., Zheng Y., Wei L., Tian T., Wu J., Jin A., Sun L.: Traditional Chinese medicine strategies to optimize antibiotic use and reduce the burden of antibiotic resistance in Chinese children. Front Public Health 2024, 12, 1530018, doi: 10.3389/fpubh.2024.1530018.
- Zhang Y., Tan P., Zhao Y., Ma X.: Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota. Gut Microbes 2022, 14, 2055943, doi: 10.1080/19490976.2022.2055943.
- Zhao A., Sun J., Liu Y.: Understanding bacterial biofilms: from definition to treatment strategies. Front Cell Infect Microbiol 2023, 13, 1137947, doi: 10.3389/fcimb.2023.1137947.
- Zhao T., Tang H., Xie L., Zheng Y., Ma Z., Sun Q., Li X.: Scutellaria baicalensis Georgi. (Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J Pharm Pharmacol 2019, 71, 1353–1369, doi: 10.1111/jphp.13129.
- Zhong Y., Tang L., Deng Q., Jing L., Zhang J., Zhang Y., Yu F., Ou Y., Guo S., Huang B., Cao H., Huang P., Xu Y.: Unraveling the novel effect of patchouli alcohol against the antibiotic resistance of Helicobacter pylori. Front Microbiol 2021, 12, 674560, doi: 10.3389/fmicb.2021.674560.
- Zhou H., Wang W., Cai L., Yang T.: Potentiation and mechanism of berberine as an antibiotic adjuvant against multidrug-resistant bacteria. Infect Drug Resist 2023, 16, 7313–7326, doi: 10.2147/IDR.S431256.
- Zhou Y., Zhang Y., Zong H., Lu X., Shen W., Zhuge B.: Chemical constituents, antibacterial activity and mechanism of Paeonia suffruticosa Andr. buds extract against Staphylococcus aureus and Escherichia coli O157:H7. Nat Prod Res 2021, 35, 1005–1009, doi: 10.1080/14786419.2019.1610961.